xtandi
astellas pharma europe b.v. - enzalutamide - prostatické nádory - endokrinná terapia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
navirel
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - vinorelbín - 44 - cytostatica
curacné 40 mg
pierre fabre dermatologie, francúzsko - izotretinoín - 46 - dermatologica
galantamin viatris 8 mg
viatris limited, Írsko - galantamín - 06 - psychostimulantia (nootropne lieČ., analeptika)
galantamin viatris 16 mg
viatris limited, Írsko - galantamín - 06 - psychostimulantia (nootropne lieČ., analeptika)
galantamin viatris 24 mg
viatris limited, Írsko - galantamín - 06 - psychostimulantia (nootropne lieČ., analeptika)
robicold rapid 200 mg/30 mg mäkké kapsuly
glaxosmithkline consumer healthcare czech republic s.r.o., Česká republika - ibuprofén, kombinácie - 07 - analgetica, antipyretica
oxykodon/naloxon mylan 40 mg/20 mg tablety s predĺženým uvoľňovaním
mylan ireland limited, Írsko - oxykodón a naloxón - 65 - analgetica - anodyna
oxykodon/naloxon mylan 30 mg/15 mg tablety s predĺženým uvoľňovaním
mylan ireland limited, Írsko - oxykodón a naloxón - 65 - analgetica - anodyna
oxykodon/naloxon mylan 20 mg/10 mg tablety s predĺženým uvoľňovaním
mylan ireland limited, Írsko - oxykodón a naloxón - 65 - analgetica - anodyna